Get started
Author

Megan Kennedy

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
2011 · Timothy S Maughan, Richard A Adams, et al. · The Lancet · 958
Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
2013 · José Baselga, Patricia Gómez, et al. · Journal of Clinical Oncology · 363
PDF
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
2011 · Richard A Adams, Angela M Meade, et al. · The Lancet Oncology · 264
Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy
2006 · John V. Reynolds, Narayanasamy Ravi, et al. · Journal of Thoracic and Cardiovascular Surgery · 121
Improvement in histological endpoints of MAFLD following a 12‐week aerobic exercise intervention
2020 · Philip O’Gorman, Sara Naimimohasses, et al. · Alimentary Pharmacology & Therapeutics · 92
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study
2011 · Miguel Martin, Henri Roche, et al. · The Lancet Oncology · 77
Combination of SELDI-TOF-MS and Data Mining Provides Early-stage Response Prediction for Rectal Tumors Undergoing Multimodal Neoadjuvant Therapy
2007 · Fraser M. Smith, William M. Gallagher, et al. · Annals of Surgery · 68
Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial
2013 · J. M. Broderick, E. Guinan, et al. · Journal of Cancer Survivorship · 53
Testing the ‘teachable moment’ premise: does physical activity increase in the early survivorship phase?
2013 · J. M. Broderick, J. Hussey, et al. · Supportive Care in Cancer · 43
Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different
2013 · Julie M. Broderick, Juliette Hussey, et al. · Journal of Geriatric Oncology · 37
PDF
ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction.
2014 · Niamh Keegan, Fionnuala Keane, et al. · Journal of Clinical Oncology · 33
A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen
2021 · Megan Kennedy, Philip O’Gorman, et al. · Haemophilia · 30
Differential Effects of Dietary versus Exercise Intervention on Intrahepatic MAIT Cells and Histological Features of NAFLD
2022 · Sara Naimimohasses, Philip O’Gorman, et al. · Nutrients · 21
PDF
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”
2021 · Niamh M. Keegan, Simon J. Furney, et al. · Cancers · 19
PDF
Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia
2022 · Megan Kennedy, Sheila Roche, et al. · Haemophilia · 18
PDF
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
2013 · J. Crown, M.J. Kennedy, et al. · Annals of Oncology · 18
Cytotoxic chemotherapy for pregnancy-associated breast cancer: single institution case series
2009 · Patrick G Morris, Fionnuala King, et al. · Journal of Oncology Pharmacy Practice · 18
Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study
2022 · Megan Kennedy, Brian O’ Mahony, et al. · European Journal Of Haematology · 17
PDF
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
2017 · Helena M Earl, Louise Hiller, et al. · The Lancet Oncology · 17
Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor
2023 · Einas Elsheikh, Michelle Lavin, et al. · Journal of Thrombosis and Haemostasis · 13
PDF
Associations Among Physical Activity, Skeletal Related Events, and Patient Reported Outcomes in Patients with Bone Metastases
2022 · Emer M. Guinan, Kate Devenney, et al. · Seminars in Oncology Nursing · 12
PDF
A phase Ib trial of copanlisib and tratuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”.
2018 · Niamh M. Keegan, Janice Maria Walshe, et al. · Journal of Clinical Oncology · 9
Catastrophic Anti-phospholipid Syndrome in the Absence of IgG Anti-cardiolipin Antibodies
1995 · M. Kennedy, J. Jackson, et al. · Scandinavian Journal of Rheumatology · 7
Implementing a physiotherapy led cancer exercise programme in a National Cancer Centre: the FIXCAS study
2023 · Kate Devenney, Niamh Murphy, et al. · Physiotherapy · 6
PDF
Improvement in cognitive impairment following a 12‐week aerobic exercise intervention in individuals with non‐cirrhotic chronic hepatitis C
2020 · Philip O’Gorman, Orla Strahan, et al. · Journal of Viral Hepatitis · 6
Works count: 48
Citation count: 2,353
H-index: 17
I10-index: 21
Year
Topic
Type